Recent News for ERNA - Eterna Therapeutics Inc.

Date	Title
Nov 14	Eterna Therapeutics regains Nasdaq compliance
Nov 14	Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing
Oct 30	Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
Oct 18	Eterna, Factor announce license, collaboration agreement
Oct 17	Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases